Cliff Asness’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Cliff Asness’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Sell	2,582 -24	-0.9%	-$2.16K	﹤0.01%	3702
2026 Q1	$226K	Buy	+2,606	New	+$228K	﹤0.01%	3552

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Cliff Asness's IHE Position: Q2 2026 in Review

Cliff Asness reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.92% in Q2 2026, selling an estimated $2.16K and leaving 2,582 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3702.

Cliff Asness first reported a position in IHE in Q1 2026 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Cliff Asness held 2,582 shares of iShares US Pharmaceuticals ETF worth $256K as of Q2 2026.
Cliff Asness sold 24 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $2.16K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3702 holding.
Cliff Asness first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.